Wang P.-HHo C.-HChen Y.-JHorng H.-CChang Y.-HChao H.-TYen M.-SSONG-NAN CHOWBOR-CHING SHEUWen K.-CChang Y.-WTsui K.-HHung M.-JHuang B.-SChen R.-JYIH-RON LIENWEN-CHUN CHANGTING-CHEN CHANGLiu J.-YWu W.-YChen T.-CHuang J.-PHung J.-HChen K.-HLai T.-HTzeng C.-RWang C.-J.2020-02-192020-02-1920151028-4559https://scholars.lib.ntu.edu.tw/handle/123456789/460742[SDGs]SDG3bisphosphonic acid derivative; calcium; dienogest; Epimedium extract; estradiol; fibrin glue; gestagen; gonadorelin agonist; nonsteroid antiinflammatory agent; oral contraceptive agent; parathyroid hormone derivative; raloxifene; tamoxifen; vitamin D; adenoid cystic carcinoma; adjuvant radiotherapy; Bartholin gland; behavior change; cancer hormone therapy; Chinese medicine; chronic pain; comorbidity; endometriosis; endometrium tumor; Epimedium; estradiol blood level; external beam radiotherapy; female; female genital tract cancer; female subfertility; fragility fracture; gynecologic surgery; human; laparoscopic surgery; Letter; meta analysis (topic); pelvic organ prolapse; physical disability; postmenopause; postmenopause osteoporosis; pregnancy rate; primary tumor; quality of life; sexual function; shoulder pain; strategic planning; Taiwan; uterus myoma; vaginal hysterectomy; vitamin supplementation; Genital Diseases, Female; gynecology; medical society; Female; Genital Diseases, Female; Gynecology; Humans; Societies, Medical; Taiwanletter10.1016/j.tjog.2015.10.022267010132-s2.0-84949309907